Inventor
SEAN STEVENS
Inventor
US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A01KAnimal husbandry23%
C12NMicroorganisms or enzymes23%
A61KPreparations for medical, dental or toiletry purposes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations3%
B60HArrangements of heating, cooling, ventilating or other air-treating devices specially adapted for passenger or goods spaces of vehicles2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
12,582,105Genetically modified T cell receptor mice202612,543,713Mice that make heavy chain antibodies202612,486,335Mice that make VL binding proteins202512,433,266Humanized light chain mice202512,402,611Genetically modified mice and engraftment202512,389,888Mice expressing a limited immunoglobulin light chain repertoire202512,310,340Humanized IL-4 and IL-4Ra animals202512,239,111Humanized IL-6 and IL-6 receptor202512,227,754Adenoviral expression vector and methods and cell lines for production202512,207,628ADAM6 mice202512,127,537Genetically modified non-human animals and methods of use thereof202412,127,536Humanized M-CSF mice202412,049,488Modular synthetic receptors and methods of use202412,036,288Methods of using humanized FCgR mice to assay Fc regions202411,963,521Humanized IL-4 and IL-4Ra animals202411,950,578ADAM6 mice202411,778,995Genetically modified non-human animals and methods of use thereof202311,766,032Genetically modified non-human animals expressing human EPO202311,666,040Humanized non-human animals with restricted immunoglobulin heavy chain loci202311,617,357Humanized light chain mice202311,612,151Humanized light chain mice202311,576,356Genetically modified non-human animals and methods of use thereof202311,559,050Humanized non-human animals with restricted immunoglobulin heavy chain loci202311,528,895Genetically modified T cell receptor mice202211,370,843High affinity antibodies to human IL-6 receptor202211,357,217Humanized universal light chain mice202211,234,419Mice that make heavy chain antibodies202211,219,195Genetically modified major histocompatibility complex mice202211,186,848Non-human animals expressing humanized C1Q complex2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to REGENERON PHARMA (27)· patent assignee history
2021–2026Based in US· patent location history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (2)· patent assignee history
2023–2025Patents assigned to INSTITUTE FOR RES IN BIOMEDICINE IRB (6)· patent assignee history
2023–2025Patents assigned to UNIV YALE (6)· patent assignee history
2024–2025Patents assigned to LUNG BIOTECHNOLOGY PBC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 27 | 2021–2026 |
| INSTITUTE FOR RES IN BIOMEDICINE IRB | 6 | 2023–2025 |
| UNIV YALE | 6 | 2023–2025 |
| LUNG BIOTECHNOLOGY PBC | 2 | 2024–2025 |
| REGENERAN PHARMACEUTICALS INC | 2 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 29 | 2021–2026 |